Group B streptococci: determinants of invasive neonatal infection.
D000907:Antibodies, Bacterial / Q000032:analysis / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology; D003170:Complement Pathway, Alternative; D003171:Complement Pathway, Classical; D036861:Delivery, Obstetric; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007231:Infant, Newborn; D008581:Meningitis / Q000209:etiology; D009504:Neutrophils / Q000276:immunology; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012141:Respiratory Tract Infections / Q000473:pathology; D018805:Sepsis / Q000209:etiology; D012703:Serotyping; D013290:Streptococcal Infections / Q000151:congenital / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D013292:Streptococcus agalactiae / Q000145:classification / Q000254:growth & development / Q000302:isolation & purification / Q000472:pathogenicity
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D007074:Immunoglobulin G; D011135:Polysaccharides, Bacterial